MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    A study of factors causing psychiatric abnomalities in patients with Parkinson’s disease

    T. Syed, R. Borgohain (Hyderabad, India)

    Objective: To study the effect of disease duration , age of the patient, MOCA on neuropsychiatric manifestations in Fifty PD patients. Background: Neuro psychiatric symptoms…
  • 2019 International Congress

    Pain in patients with multiple system atrophy: a pain-related evoked potential study

    M. Takeda, F. Okada, H. Tachibana, S. Kasama, H. Yoshikawa (Nishinomiya, Japan)

    Objective: The purpose of this study was to investigate the pathophysiology of pain in patients with multiple system atrophy (MSA). Background: MSA is an atypical…
  • 2019 International Congress

    Neuroprotective effect of crocus sativus in lead-induced dopaminergic neurotoxicity in Meriones shawi: A possible link with Parkinson’s disease

    L. Tamegart, A. Abbaoui, R. Makbal, M. Zroudi, M. Bouyatas, B. Bouizgarne, H. Gamrani (Marrakesh, Morocco)

    Objective: In this study, we have evaluated, in one hand, the neurotoxic effect of Pb (25 mg / kg B.W i.p) for three consecutive days…
  • 2019 International Congress

    Does Anticholinergic Burden Affect the Outcomes in Patients Diagnosed with Parkinson’s Disease?

    S. Taylor, E. Jones (York, United Kingdom)

    Objective: To explore the impact of an anticholinergic burden on various outcomes in Parkinson’s disease. Background: Over 600 different medications possess some anticholinergic effect.[1] There…
  • 2019 International Congress

    Impact of a high-fat diet on the behavior of A53T alpha-Synuclein Parkinson’s disease mice

    M. Temmel, V. Niederkofler, R. Rabl, H. Roemer, B. Hutter-Paier (Grambach, Austria)

    Objective: The aim of this project was to evaluate high-fat diet (HFD) induced behavioral alterations in the A53T alpha-Synuclein Parkinsons’s disease mouse model. Background: Besides…
  • 2019 International Congress

    The effect of active contact localization on motor symptoms in deep brain stimulation of the subthalamic nucleus for Parkinson’s disease

    T. Ten Brinke, V. Odekerken, P. Schuurman, R. de Bie (Amsterdam, Netherlands)

    Objective: To evaluate whether implantation precision is related to the outcome of STN DBS. Background: Accurate implantation of electrodes is important for the outcome of…
  • 2019 International Congress

    Identification of potential new genes involved in autosomal recessive forms of Parkinson’s disease

    C. Tesson, A. Honoré, V. Drouet, H. Bertrand, S. Lesage, A. Brice (Paris, France)

    Objective: The aim of the work is to identify new genes involved in autosomal recessive (AR) early-onset (EO, >40 years) Parkinson disease (PD), using consanguineous…
  • 2019 International Congress

    Impact of quantitative assessment of parkinsonian symptoms using wearable technology on treatment decisions

    C. Thomas, B. Mohamed, M. Silverdale, C. Kobylecki, L. Osborne, R. Saha, P. Bain, D. Heisters, C. Carroll (Cardiff, United Kingdom)

    Objective: We evaluated the impact on routine treatment decisions of using the Parkinson’s KinetiGraph(PKG) to provide objective patient information Background: Continuous objective measurements using wearable technology may…
  • 2019 International Congress

    Using Quantitative Susceptibility Mapping to Predict Dementia in Parkinson’s Disease

    G. Thomas, L. Leyland, J. Acosta-Cabronero, R. Weil (London, United Kingdom)

    Objective: To investigate how brain iron deposition relates to visual function and dementia risk in Parkinson’s Disease (PD). Background: Oxidative stress due to brain iron…
  • 2019 International Congress

    A characterization of the ADL-level in daily life with Parkinson`s Disease based on objective measurements and subjective experiences.

    T. Thomsen, T. Kjær, L. Jørgensen, A. Haahr, K. Winge (Roskilde, Denmark)

    Objective: 1. Test whether slow response to the medication and EMO-periods (Early Morning Off), affects the patient`s experience of being able to perform ADL-functions. 2.…
  • « Previous Page
  • 1
  • …
  • 1302
  • 1303
  • 1304
  • 1305
  • 1306
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley